New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Kaklamani and Dr. O’Regan
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Meisel & Dr. Soliman
ICD-10-PCS 2025: Other Changes
Oncology Billing Updates
ICD-10-CM: Tabular List Changes 2025
Live Webinar - Update in the Management of HR+HER2-ABC - 8 PM
Breast Cancer and the Immune System at MBC Patient Forum 2019
Yale Cancer Center Grand Rounds | February 21, 2023
Loco - Regional Breast Cancer | Dr. Joy Ghose
Rewriting the Textbook on Disease
SABCS11 PC_ Dawn Hershman_ Influence of Hospital Factors, Physician Factors and
Comment: CDK4/6 inhibitors in advanced breast cancer
AC22 - Session III :: Targeted Therapies and Overcoming Resistance
Final alpelisib presentation
Patients with High Risk Features | 2023 Best of Breast Conference
Medical Coding Exam Questions on Disease
Special Lecture I&II: Extrapolating data from clinical trials as we are treating patients in rea...
Quantitative Data Sciences Core Clinical Informatics: Clinical Data for Cancer Research
Research Forum #9: Cancer
Using Impedance-Based Approaches for Measuring Antigen-Specific Cytotoxic T cell Activity